Drugs Made In America Acquisition (DMIIR) Total Non-Current Liabilities (2025 - 2026)
Drugs Made In America Acquisition (DMIIR) posted quarterly Total Non-Current Liabilities of $17.5 million for Q4 2025.
Powered by 
Analysis
Drugs Made In America Acquisition (DMIIR) Total Non-Current Liabilities (2025 - 2026) Analysis & Trends
Drugs Made In America Acquisition (DMIIR) has reported Total Non-Current Liabilities for 1 consecutive years, with $17.5 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Non-Current Liabilities changed N/A year-over-year to $17.5 million; the TTM figure through Dec 2025 stood at $17.5 million (changed N/A YoY), while the FY2025 annual figure was $17.5 million, changed N/A from the prior year.
- Total Non-Current Liabilities held at $17.5 million in Q4 2025 per DMIIR's latest filing.
- Across five years, Total Non-Current Liabilities topped out at $17.5 million in Q4 2025 and bottomed at $17.5 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - | - |
| 2 | Agriculture & Natural Solutions Acquisition | 853.42 Mn | 853.17 Mn | - | 34.24 Mn |
| 3 | K&F Growth Acquisition | 836.15 Mn | 836.15 Mn | - | - |
| 4 | Armada Acquisition | 666.23 Mn | 666.18 Mn | - | - |
| 5 | Pioneer Acquisition I | 652.74 Mn | 652.27 Mn | - | - |
| 6 | Oxley Bridge Acquisition | 652.11 Mn | 652.11 Mn | - | - |
| 7 | Titan Acquisition | 651.43 Mn | 941.85 Mn | - | - |
| 8 | GSR IV Acquisition | 622.22 Mn | 622.22 Mn | - | 9.07 Mn |
| 9 | Launch One Acquisition | 618.70 Mn | 618.70 Mn | - | - |
| 10 | Drugs Made In America Acquisition | 5.10 Mn | 5.10 Mn | - | 17.50 Mn |